# Avontec

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avontec

- Industry: Pharmaceuticals
- Headquarters: Germany
- Total disclosed funding: $18M
- Latest round: Series B (Aug 11, 2005)
- Investors on record: 4

## About

Founded in 2001, Avontec GmbH is the development and commercialization of nucleic acid-based therapeutic treatments for inflammatory diseases.

## Funding rounds

- Series B, Aug 11, 2005, $18M — InnovationsKapital, Mediport Venture, BioMed Partners, Deutsche Venture Capital

## Investors

- InnovationsKapital (https://capitalatlas.ai/funds/innovationskapital) — Series B
- Mediport Venture (https://capitalatlas.ai/funds/mediport-venture) — Series B
- BioMed Partners (https://capitalatlas.ai/funds/biomed-partners) — Series B
- Deutsche Venture Capital (https://capitalatlas.ai/funds/deutsche-venture-capital) — Series B